Literature DB >> 30481629

Medial Branch Block Versus Vertebroplasty for 1-Level Osteoporotic Vertebral Compression Fracture: 2-Year Retrospective Study.

In-Suk Bae1, Hyoung-Joon Chun2, Koang-Hum Bak1, Hyeong-Joong Yi1, Kyu-Sun Choi1, Kee D Kim3.   

Abstract

OBJECTIVE: Percutaneous vertebroplasty (VP) and medial branch block (MBB) are used to treat osteoporotic vertebral compression fractures (VCF). We compared the clinical outcomes, radiologic changes, and economic results of MBB with those of VP in treating osteoporotic VCFs.
METHODS: A total of 164 patients with 1-level osteoporotic VCF were reviewed retrospectively. The clinical outcomes were measured with a visual analogue scale (VAS) and the Oswestry Disability Index (ODI). To compare economic costs between groups, total hospital costs at the last follow-up day were calculated.
RESULTS: The patients were divided into 2 groups: 72 patients in the conservative group treated by MBB (MBB group) and 92 patients in the group who underwent VP (VP group). The VAS and ODI scores improved significantly within postoperative week 1 in the VP group compared with the MBB group. However, the VAS and ODI scores did not differ between the groups after 1 postoperative year. After 2 years of follow-up, 14 new fractures occurred in the VP group and 3 in the MBB group. The improvement in compression ratio was statistically greater in the VP group than in the MBB group. However, after 2 years the radiologic changes between groups did not differ statistically. After the final follow-up visits, the hospital costs were significantly lower in the MBB group.
CONCLUSIONS: After 2 years of follow-up, VP and MBB both had similar efficacy in terms of pain relief and radiologic changes. MBB was more cost effective than VP. Thus, MBB alone can be a possible alternative to VP in patients with 1-level osteoporotic VCFs.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Medial branch block; Osteoporosis; Vertebral compression fracture; Vertebroplasty

Mesh:

Year:  2018        PMID: 30481629     DOI: 10.1016/j.wneu.2018.11.142

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  2 in total

1.  The Acute VertEbRal AugmentaTion (AVERT) study: protocol for a randomised controlled, feasibility trial of spinal medial branch nerve block in hospitalised older patients with vertebral fragility fractures.

Authors:  Chia Wei Tan; Maribel Cameron; Yuriy Arlachov; Anastasios Bastounis; Simon Bishop; Michal Czernicki; Avril Drummond; Apostolos Fakis; Dritan Pasku; Opinder Sahota
Journal:  BMJ Open       Date:  2022-06-13       Impact factor: 3.006

Review 2.  Can facet joint block be a complementary or alternative therapeutic option for patients with osteoporotic vertebral fractures: a meta-analysis.

Authors:  Zhi Chen; Chenyang Song; Jianwen Chen; Jun Sun; Wenge Liu
Journal:  J Orthop Surg Res       Date:  2022-01-21       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.